Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.0082 | 0.9 |
mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |
mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.0079 | 0.9 |
mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.9 |